Evelo Biosciences (EVLO) Competitors $0.0003 0.00 (0.00%) (As of 11/4/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsInsider TradesOwnershipSEC FilingsTrends EVLO vs. SCPS, STAB, ARDS, GNCA, AMPE, CMRA, EFTR, ONCSQ, ATNFW, and LBPSWShould you be buying Evelo Biosciences stock or one of its competitors? The main competitors of Evelo Biosciences include Scopus BioPharma (SCPS), Statera Biopharma (STAB), Aridis Pharmaceuticals (ARDS), Genocea Biosciences (GNCA), Ampio Pharmaceuticals (AMPE), Comera Life Sciences (CMRA), eFFECTOR Therapeutics (EFTR), OncoSec Medical (ONCSQ), 180 Life Sciences (ATNFW), and 4D pharma (LBPSW). These companies are all part of the "pharmaceutical products" industry. Evelo Biosciences vs. Scopus BioPharma Statera Biopharma Aridis Pharmaceuticals Genocea Biosciences Ampio Pharmaceuticals Comera Life Sciences eFFECTOR Therapeutics OncoSec Medical 180 Life Sciences 4D pharma Evelo Biosciences (NASDAQ:EVLO) and Scopus BioPharma (NASDAQ:SCPS) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, earnings, profitability, community ranking, dividends, risk, institutional ownership, media sentiment and analyst recommendations. Does the MarketBeat Community prefer EVLO or SCPS? Evelo Biosciences received 168 more outperform votes than Scopus BioPharma when rated by MarketBeat users. However, 100.00% of users gave Scopus BioPharma an outperform vote while only 60.50% of users gave Evelo Biosciences an outperform vote. CompanyUnderperformOutperformEvelo BiosciencesOutperform Votes17060.50% Underperform Votes11139.50% Scopus BioPharmaOutperform Votes2100.00% Underperform VotesNo Votes Does the media refer more to EVLO or SCPS? In the previous week, Evelo Biosciences had 1 more articles in the media than Scopus BioPharma. MarketBeat recorded 1 mentions for Evelo Biosciences and 0 mentions for Scopus BioPharma. Evelo Biosciences' average media sentiment score of 0.64 beat Scopus BioPharma's score of 0.00 indicating that Evelo Biosciences is being referred to more favorably in the media. Company Overall Sentiment Evelo Biosciences Positive Scopus BioPharma Neutral Which has more volatility & risk, EVLO or SCPS? Evelo Biosciences has a beta of 1.28, suggesting that its share price is 28% more volatile than the S&P 500. Comparatively, Scopus BioPharma has a beta of -0.01, suggesting that its share price is 101% less volatile than the S&P 500. Do institutionals & insiders hold more shares of EVLO or SCPS? 0.3% of Evelo Biosciences shares are held by institutional investors. 1.0% of Evelo Biosciences shares are held by insiders. Comparatively, 5.1% of Scopus BioPharma shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Do analysts prefer EVLO or SCPS? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Evelo Biosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AScopus BioPharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Is EVLO or SCPS more profitable? Company Net Margins Return on Equity Return on Assets Evelo BiosciencesN/A N/A N/A Scopus BioPharma N/A N/A N/A Which has stronger earnings & valuation, EVLO or SCPS? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEvelo BiosciencesN/AN/A-$114.53M-$13.290.00Scopus BioPharmaN/AN/A-$11.61MN/AN/A SummaryEvelo Biosciences beats Scopus BioPharma on 5 of the 8 factors compared between the two stocks. Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Get Evelo Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EVLO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EVLO vs. The Competition Export to ExcelMetricEvelo BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$6,000.00$6.75B$5.04B$8.43BDividend YieldN/A7.94%7.52%4.16%P/E Ratio0.0012.17130.2316.67Price / SalesN/A270.431,720.2276.26Price / CashN/A46.0936.9133.54Price / Book0.005.284.604.98Net Income-$114.53M$151.33M$114.94M$224.26M7 Day PerformanceN/A0.30%0.14%1.65%1 Month PerformanceN/A14.88%10.15%6.92%1 Year PerformanceN/A36.87%33.87%26.46% Evelo Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EVLOEvelo BiosciencesN/A$0.00flatN/A-99.9%$6,000.00N/A0.00120SCPSScopus BioPharmaN/A$0.00-20.0%N/AN/A$17,000.00N/A0.009Gap DownHigh Trading VolumeSTABStatera BiopharmaN/A$0.00flatN/A-97.0%$16,000.00$1.49M0.0020Gap DownARDSAridis Pharmaceuticals0.8992 of 5 stars$0.00flat$2.00+999,900.0%-99.8%$11,000.00$3.09M0.0030Gap UpGNCAGenocea BiosciencesN/A$0.00flatN/AN/A$6,000.00$1.91M0.0070Analyst ForecastAMPEAmpio PharmaceuticalsN/A$0.00flatN/A-99.9%$3,000.00N/A0.0020CMRAComera Life SciencesN/A$0.00-50.0%N/AN/A$3,000.00$630,000.000.002Gap DownEFTReFFECTOR TherapeuticsN/A$0.00flat$24.00+5,999,900.0%-100.0%$2,000.00$3.55M0.0010ONCSQOncoSec MedicalN/A$0.00+∞N/AN/A$1,000.00N/A0.0040Gap UpATNFW180 Life SciencesN/A$0.01flatN/A+0.0%$0.00N/A0.007LBPSW4D pharmaN/A$0.04-25.7%N/AN/A$0.00$522,000.000.00N/AGap Down Related Companies and Tools Related Companies SCPS Alternatives STAB Alternatives ARDS Alternatives GNCA Alternatives AMPE Alternatives CMRA Alternatives EFTR Alternatives ONCSQ Alternatives ATNFW Alternatives LBPSW Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:EVLO) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evelo Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evelo Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
